Nizamabad: The Nizamabad district administration is gearing up to administer the Covid-19 vaccine to elderly persons aged more than 60 years and those aged above 40 years with comorbidities .
On Sunday, Nizamabad collector Narayana Reddy conducted a review meeting with medical and health officials through a teleconference on the Covid-19 vaccination programme. He informed that till now, the Covid-19 vaccine was administered to the frontline workers and healthcare employees and the government gave its nod to administer the vaccine to general public in a phased manner. Initially, the vaccine will be administered to people who crossed 60 years age and those who are aged above 40 years and having health issues, from March 1. The Medical and Health department officials completed necessary arrangements in this regard.
Collector Narayana Reddy said the Covid -19 vaccine will be administered at Nizamabad government general hospital and two private nursing homes – Pragathi hospital and Medicover hospital. While the vaccine will be provided at free of cost in the government hospital, private nursing homes will charge Rs 150 for vaccine and Rs 100 rupees towards service charges. “Those who intend to take the vaccine should register their names on the http://cowin.gov.in website by providing their mobile numbers on the website and they should arrive for vaccination, along with their age proofs like Aadhar card and their health records,” he said.
Narayana Reddy also informed that along with the said persons, vaccination will be conducted to the frontline workers who missed first or second dose vaccination earlier, covering at least 200 persons. He ordered the DMHO to makee arrangements for vaccination and supervise the vaccination in private nursing homes.
DMHO Dr Sudershanam, GGH superintendent Dr Prathima Raj, Deputy DMHO Dr. Thukaraam, private nursing home representatives participated.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.
Click to follow Telangana Today Facebook page and Twitter .